Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALDH2 polymorphism and nitroglycerin response in coronary artery disease
ChiCTR-TRC-13003876Phase 4Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nitroglycerin in coronary arteriosclerosis, sponsored by Xiangya Hospital, Central South University. Primary endpoints: ALDH2 polymorphism, Calcitonin gene-related peptide and 2 more. Started Feb 2010; status: completed.
02
Drugs
nitroglycerin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-13003876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003876.